Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.50
Bid: 17.00
Ask: 20.00
Change: 0.00 (0.00%)
Spread: 3.00 (17.647%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 18.50
STCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dividend Proposal and Nomination of Director

13 Jun 2022 07:00

RNS Number : 6046O
Steppe Cement Limited
13 June 2022
 

13 June 2022

Steppe Cement Ltd

Dividend Proposal and Nomination of Director

 

The Board of Steppe Cement Ltd (Steppe Cement or Company) wish to draw the attention of shareholders to the following matters:

 

Dividend proposal

 

The Board wishes to recommend the distribution of a 5p dividend in respect of 2021. However new regulations in Malaysia have created uncertainty about the tax treatment of foreign sourced dividend income for Malaysian corporates - meaning that income to Steppe Cement Sdn Bhd may be subject to a 24% withholding tax. Therefore before declaring the dividend, the Board is waiting for clarification regarding the exemption to this tax. It is the understanding of the Board that confirmation from the Malaysian authorities will be forthcoming shortly. The Kazakh subsidiaries already pay 20% profit tax in Kazakhstan.

 

If the tax issue cannot be resolved without payment of the 24% rate, the Board will evaluate other means of returning capital to shareholders.

 

Proposal by Substantial Shareholder on Nomination of Director

 

The Board has received notification from Wan Azmi Wan Hamzah, the Company's largest shareholder (representing more than 30% of the shares of the Company) to propose his son, Wan Affan Wan Azmi, be appointed to the Board to represent his family interest in the Company.

 

The Board has agreed to put the corresponding item in the agenda of the Annual General Meeting (AGM) of shareholders. The profile of Wan Affan Wan Azmi is appended below for shareholders information.

 

Wan Affan Wan Azmi will be deemed to be a Non-Independent Non-Executive Director due to his family relationship and indirect interests in Steppe Cement.

 

In case the resolution is approved at the AGM, the number of Independent Directors in the Company will be 50%, 2 out of 4. The Non-Executive Chairman will retain a casting vote in case of a tie in the board decisions.

 

Javier del Ser

On behalf of Board of Directors

 

Wan Affan Wan Azmi

 

Wan Affan Wan Azmi, 35, is currently the Chief Operating Officer (COO), Rohas-Euco Industries Berhad. He joined Rohas-Euco Industries Berhad in 2013 as a Business Executive, initially in Marketing and later directly involved in IT, Media and Communications. In 2019, he was assigned as Assistant to the COO, then promoted to Deputy COO in January 2020 and subsequently as COO in October 2020. He is currently running the day-to-day operations at both headquarters in Kuala Lumpur as well as the manufacturing facilities in Bentong, Pahang in Malaysia

 

Wan Affan Wan Azmi is the son of Steppe Cement Ltd's (Steppe Cement or Company) largest shareholder, Wan Azmi Wan Hamzah, who currently holds 31% interest in Steppe Cement via Halfmoon Bay Capital Limited, Mango Bay Enterprises Inc. and Alwaha Fund Limited.

 

Wan Affan Wan Azmi has under 20% direct beneficial interests in each of the above entities that holds shares in the Company. He currently holds or has held the following directorship or partnership in the last five years:

 

Current Directorship

Past Directorship

None

None

 

Wan Affan Wan Azmi has not been involved with any unspent convictions in relation to indictable offences, bankruptcy, creditors voluntary arrangements, receiverships, compulsory liquidations, creditors voluntary liquidations, administrations, public criticisms or other matters which require disclosure pursuant to Schedule 2(g) of the AIM rules.

 

There are no other matters in relation to Wan Affan Wan Azmi that is required to be disclosed pursuant to Schedule 2(g) of the AIM Rules for Companies.

Steppe Cement's AIM nominated adviser and broker is RFC Ambrian Limited.

Nominated Adviser contact: Stephen Allen or Andrew Thomson on +61 8 9480 2500.

Broker contact: Charlie Cryer at +44 20 3440 6800

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVUOUARURUNARR
Date   Source Headline
1st Oct 20207:00 amRNSAppointment of Alternate Directors
21st Sep 20207:00 amRNSHolding(s) in Company
16th Sep 20207:00 amRNSInterim Results and General Market Update
2nd Sep 20207:00 amRNSPurchase of Shares by Substantial Shareholder
9th Jul 20207:00 amRNSFY2019 Dividend Dates
9th Jul 20207:00 amRNSMarket Update for the First Half of 2020
9th Jul 20207:00 amRNSAGM Results
10th Jun 20207:00 amRNSNotice of AGM
10th Jun 20207:00 amRNSFinal Results and Accounts 2019
14th Apr 20207:00 amRNS1st Quarter Results
10th Jan 20208:19 amRNSPreliminary Results
7th Oct 20197:00 amRNSMarket Update for the 3rd Quarter
12th Sep 20197:00 amRNSInterim Results and General Market Update
23rd Jul 20197:00 amRNSHolding(s) in Company
10th Jul 20197:00 amRNSMarket Update for the First Half of 2019
20th Jun 20199:41 amRNSHolding(s) in Company
13th Jun 20197:00 amRNSFinal Dividend FY2018
13th Jun 20197:00 amRNSAGM Results
15th May 20197:00 amRNSAnnual Report 2018 and Notice of AGM
15th May 20197:00 amRNSCEO Statement 2018
23rd Apr 20197:00 amRNSHoldings in Company
10th Apr 20197:00 amRNSMarket update for the quarter ended 31 March 2019
4th Mar 20194:35 pmRNSPrice Monitoring Extension
20th Feb 20197:00 amRNSHoldings in Company
10th Jan 20197:00 amRNSPreliminary Update for Year ended 31 December 2018
23rd Oct 20187:00 amRNSChange in Substantial Shareholders' Interests
8th Oct 20187:21 amRNSMarket Update for 3Q ended 30 September 2018
18th Sep 20187:00 amRNSInterim Results
13th Jul 20187:00 amRNSHolding(s) in Company
11th Jul 20187:00 amRNSMarket update for first half of 2018
25th Jun 20187:00 amRNSHolding(s) in Company
19th Jun 20187:00 amRNSDividend Announcement
15th Jun 20187:00 amRNSAGM Results
29th May 20187:00 amRNSAnnual Report 2017 and Notice of AGM
29th May 20187:00 amRNSResults and Annual Report 2017
12th Apr 20187:00 amRNSMarket update for the quarter ended 31 March 2018
15th Jan 20187:00 amRNSPreliminary Update for Year Ended 31 December 2017
8th Dec 20177:00 amRNSNew Significant Shareholder
17th Nov 20177:00 amRNSRepayment of Bonds
12th Oct 20177:00 amRNSAppointment of Independent Non-Executive Director
11th Oct 20177:00 amRNSMarket update for 3Q ended 30 September 2017
13th Sep 20177:00 amRNSInterim Results
15th Jun 20177:00 amRNSAGM Results
23rd May 20177:00 amRNSAnnual Report 2016
22nd May 20177:00 amRNSResults and Annual Report for 2016
13th Apr 20177:00 amRNSMarket update for March quarter
13th Jan 20177:00 amRNSPreliminary Update for Year Ended 31 December 2016
20th Dec 20167:00 amRNSHoldings in Company
29th Nov 20168:33 amRNSRefinancing and extension of loans
15th Nov 20167:00 amRNSPurchase of Shares by Substantial Shareholder

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.